Does IMATINIB Cause Capillary leak syndrome? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Capillary leak syndrome have been filed in association with IMATINIB (Imatinib). This represents 0.0% of all adverse event reports for IMATINIB.
18
Reports of Capillary leak syndrome with IMATINIB
0.0%
of all IMATINIB reports
1
Deaths
4
Hospitalizations
How Dangerous Is Capillary leak syndrome From IMATINIB?
Of the 18 reports, 1 (5.6%) resulted in death, 4 (22.2%) required hospitalization, and 1 (5.6%) were considered life-threatening.
Is Capillary leak syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMATINIB. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does IMATINIB Cause?
Death (9,708)
Drug ineffective (2,628)
Nausea (2,379)
Diarrhoea (2,203)
Fatigue (1,810)
Malignant neoplasm progression (1,716)
Vomiting (1,599)
Malaise (1,361)
Drug intolerance (1,354)
Drug resistance (1,293)
What Other Drugs Cause Capillary leak syndrome?
GEMCITABINE (134)
TAGRAXOFUSP-ERZS (110)
PACLITAXEL (97)
CYCLOPHOSPHAMIDE (86)
DOCETAXEL (81)
CYTARABINE (68)
METHOTREXATE (65)
NIVOLUMAB (61)
RITUXIMAB (58)
FILGRASTIM (52)
Which IMATINIB Alternatives Have Lower Capillary leak syndrome Risk?
IMATINIB vs IMBRUVICA
IMATINIB vs IMDEVIMAB
IMATINIB vs IMEGLIMIN
IMATINIB vs IMETELSTAT
IMATINIB vs IMIDAPRIL